Skip to content
‹ Back to IndustriesHealthcare

CurveBeam Teams Up with the Paley Foundation to Change the Lives of Children

On June 3, the Paley Foundation hosted the Bill Bones Saving Limbs Ride to benefit the Tommy Fund, a charity for children with limb defects. The annual event features a 15 and 55-mile early morning bike ride in West Palm Beach, riding to and from Boca Raton. In addition, there is a family fun ride…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Try it Free

On June 3, the Paley Foundation hosted the Bill Bones Saving Limbs Ride to benefit the Tommy Fund, a charity for children with limb defects. The annual event features a 15 and 55-mile early morning bike ride in West Palm Beach, riding to and from Boca Raton. In addition, there is a family fun ride for bikes, scooters, or wheelchairs. CurveBeam is proud to be a sponsor of this year’s event.

The Foundation

The unLIMBited Foundation is a team of passionate individuals who offer children a chance to fulfill their dreams through limb-saving medical and surgical treatments at the world-renowned Paley Institute in West Palm Beach, Florida. When children are born with severe congenital limb defects, they are often offered amputation as a sole solution. Dr. Dror Paley and The Paley Institute, along with the unLIMBited team, advocate for an alternative solution: limb saving and corrective surgery. The Tommy Fund has been established by the joined forces of the Paley Foundation and the unLIMBited Foundation to provide much needed financial assistance to those families undergoing the extensive surgery and rehabilitation. Patient families relocate to Florida for up to six months to receive these treatments. The Tommy Fund helps those families cover the costs of this extensive and life-altering endeavor.http://www.curvebeam.com/blog/wp-content/uploads/2018/06/1-paley-fund-ride.jpg

Tommy’s Story

Tommy Morissey is an ordinary seven-year-old boy, who happens to also play golf like a pro. And he does so with only one arm. Tommy, who is the namesake of the fund, was born without much of his right arm. By age three, amazingly, he was a golf prodigy, and now at age seven, he travels the globe speaking on behalf of children like himself in an effort to increase awareness, reduce stereotypes, and raise money to help this cause.

Sponsorship by CurveBeam

The proceeds gained by the Bill Bones Saving Limbs Ride go directly to the Tommy Fund to assist families in need of medical services and living expenses during a child’s treatment. The team at CurveBeam cannot think of a better way to invest our resources than by sponsoring this incredible event. As a pioneer in the medical imaging industry, CurveBeam is deeply concerned with the health and welfare of those dealing with orthopedic and podiatric challenges. As manufacturers of Cone Beam CT imaging equipment, we believe it is essential to give back to the communities represented by the imaging patients we ultimately serve; our littlest patients hold a special place in our hearts as we aim to improve our imaging solutions continually.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512